Innovestor’s Life Science Fund

🏷️ vc
Visit Website ↗
Investment Thesis

Investing in life-saving science in the Nordics and Baltics, focusing on early-stage biotech and digital health companies that address unmet medical needs with global potential. The fund leverages the region's strong scientific and technological capabilities to drive impactful healthcare solutions.

Stage Focus
Pre-seed to Series A

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Early-stage companies developing life-saving or life-altering products for unmet medical needs with global potential

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
€250,000 - €90,000,000

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required

Investment Team (1)